1. GPCR/G Protein MAPK/ERK Pathway PI3K/Akt/mTOR
  2. Ras Raf PI3K p38 MAPK
  3. KRAS-IN-55

KRAS-IN-55 是一种泛 KRAS 抑制剂,对 KRASG12C、KRASG12D 和 KRASG12VIC50 分别为 4.3、9.6 和 1.6 nM。KRAS-IN-55 可在 KRAS 上诱导形成一个新的结合口袋,从而与亲环蛋白 A (CYPA) 形成高亲和力三元复合物,抑制 KRAS 与下游效应因子 RAFPI3K 的相互作用,并阻断致癌性 MAPKPI3K 信号通路。KRAS-IN-55 可用于结直肠癌、非小细胞肺癌等癌症研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

KRAS-IN-55

KRAS-IN-55 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

KRAS-IN-55 is a pan-KRAS inhibitor with IC50 values of 4.3, 9.6 and 1.6 nM against KRASG12C, KRASG12D and KRASG12V, respectively. KRAS-IN-55 induces the formation of a new binding pocket on KRAS, thereby forming a high-affinity ternary complex with cyclophilin A (CYPA), inhibiting the interactions of KRAS with downstream effectors RAF and PI3K, and blocking oncogenic MAPK and PI3K signaling pathways. KRAS-IN-55 is applicable to cancer research such as colorectal cancer and non-small cell lung cancer[1].

体外研究
(In Vitro)

KRAS-IN-55 (Example 2) (72 h) 可抑制 KRASG12C、KRASG12D 和 KRASG12V 突变型癌细胞的活力,在 NCI-H358 细胞中的 IC50 为 15.2 nM,在 AGS 细胞中为 10.5 nM,在 SW620 细胞中为 2.8 nM[1]
KRAS-IN-55 (0.0001-10 μM; 3 h) 可抑制 KRASG12C、KRASG12D、KRASG12V 与 BRAFrbd 之间的相互作用,其针对 KRASG12C 的 IC50 为 0.008 μM,针对 KRASG12D 的 IC50 为 0.044 μM,针对 KRASG12V 的 IC50 为 0.010 μM[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

892.09

Formula

C48H58FN9O5S

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
KRAS-IN-55
目录号:
HY-181883
需求量: